Skip to main contentSkip to navigation
Sirius Investors

MAHLY Stock: MediPal Holdings Corporation Stock Price, Analysis & Insights

Get live MAHLY stock price $19.00, comprehensive MediPal Holdings Corporation stock analysis, charts, news, and expert forecast. Real-time MAHLY stock data and investment insights.

19.00
0.00%Today
MAHLYMediPal Holdings Corporation • Other OTC • Healthcare
Market Cap
3.89B
Volume
1
52W High
20.35
52W Low
14.60

Loading chart data...

MediPal Holdings Corporation (MAHLY) Overview

MediPal Holdings Corporation (MAHLY) is a publicly traded company in the Healthcare sector , specifically within the Medical - Distribution industry . As of the latest trading session, MAHLY trades at $19.00 with a market capitalization of 3.89B . Over the past 52 weeks, MAHLY has traded between $14.60 and $20.35 , with the current price positioned at approximately 77% of this range . The stock...

Key Takeaways

  • Operates in the Healthcare sector (Medical - Distribution)
  • Market cap: 3.89B
  • Current price: $19.00
  • 52-week range: $14.60 - $20.35
  • P/E ratio: 14.73

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Medipal Holdings Corporation, a Tokyo-based Japanese company founded in 1898, primarily operates as a wholesaler of prescription pharmaceuticals throughout Japan. Beyond its core drug distribution, the company also sources and supplies a comprehensiv...

Company Information

CEO
Shuichi Watanabe
Sector
Healthcare
Industry
Medical - Distribution
Employees
13075

Contact Information

Address
2-7-15, Yaesu
Country
JP

Investment Analysis & Business Insights

Healthcare
Medical - Distribution

Investment Highlights

Strong presence in the Healthcare sector with established market position

Valuation metrics suggest potential value opportunity (P/E: 14.7)

Lower volatility stock (Beta: -0.04) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for MediPal Holdings Corporation shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for MediPal Holdings Corporation
  • Investors should consider how MediPal Holdings Corporation fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

3.89B

P/E Ratio (TTM)

14.73

Beta

-0.04

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.